Tryptamine Therapeutics (AU:TYP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tryptamine Therapeutics Limited has announced a non-pro rata offer to issue 10,000 ordinary fully paid shares, with the closing date for acceptances set for November 13, 2024. The proposed issue date for the securities is also November 13, 2024. This move is part of the company’s strategy to raise capital through the Australian Securities Exchange (ASX).
For further insights into AU:TYP stock, check out TipRanks’ Stock Analysis page.